EMarketing Banner Image

Penn State Hershey Melanoma and Skin Cancer Center

Melanoma is the leading cause of death from skin disease – and its rate of occurrence is steadily increasing. In America, one person dies of melanoma every hour. More than 60,000 new cases in the United States are diagnosed each year, and this number is growing at an alarming rate.

In an effort to fight this trend, Penn State Hershey Melanoma and Skin Cancer Center offers a multidisciplinary approach to developing new treatments for melanoma patients. The Melanoma and Skin Cancer Center convenes researchers and clinicians from surgery, dermatology, medical and radiation oncology, pharmacology, orthopedics and other areas with a goal of identifying and evaluating new agents and clinical interventions. Discoveries developed in the research portion of the Melanoma and Skin Cancer Center are tested through a portfolio of clinical trials offered to patients.

Click here to learn more about the next generation of therapies.


Melanoma Awareness

"Dead Wrong… It's Only Skin Cancer"

Dead Wrong… It's Only Skin Cancer was produced in 2008 by the Mike Geltrude Foundation of Nutley, NJ.  However, this educational documentary is not about Mike Geltrude and his battle against melanoma.  In reality, it's about you.  The reason is that anyone at any age can be afflicted by this deadly disease and one of the greatest weapons we have to combat melanoma is education.   Therefore, taking a half hour to watch this film may save your life and by spreading the word it can save countless lives.  As the saying goes, "an ounce of prevention is better than a pound of cure." -  Watch Video


Melanoma and Skin Cancer Center supports legislation to ban minors under the age of 18 from using indoor tanning beds in Pennsylvania. House Bill 977 got passed in the House and will head to the Senate shortly.  The bill bans the use of tanning beds for minors 17 years and younger.  Bill 977 is also supported by the Consortium of Melanoma Centers of PA  Members from the Center testified in front of a judiciary committee……read more. 

Clinical Trials

The Melanoma and Skin Cancer Center continues to facilitate phase I, II, and III clinical trials of new therapies in its quest to find a cure. Please contact us for information about current clinical trials.

Patient Care

The Melanoma and Skin Cancer Center Skin Oncology Program includes a multidisciplinary clinic for the treatment of melanoma. The Skin Oncology Program's goals include clinical care, research, education, and community outreach.


The Melanoma and Skin Cancer Center's research goal is to unravel the biology and signaling pathways involved in melanoma tumor development to develop the next generation of therapeutic agents to treat this disease.

For more information on the research and clinical activities of the Center, click here

Research Funding

As part of the Penn State Cancer Institute's and the Melanoma and Skin Cancer Center's ongoing efforts to advance and support translational research to find the cure, the Center announces the availability of funding to support projects.  The funds available were raised through the Annual Chocolate Tour fundraising effort. For more information on the funds available and how to apply.

Melanoma and Skin Cancer Center Visiting Scholar Lectureship

  • 2011: New Frontiers for Melanoma Centers: "Strategies for diagnosis, management and collaborative research

    • Presenter: Dr. John Thompson, M.D., Executive Director Melanoma Institute of Australia

  • 2013: Medical Therapy of Melanoma: "Have we gone from zero to sixty?"  (Watch presentation)

    • Presenter: Dr. Sanjiv S. Agarwala, M.D., Director, Melanoma and Immunotherapy Program, St. Luke's Hospital, Temple University

  • 2014: "The Evolution of Adjuvant Therapy for Human Melanoma"

    • Presenter: Dr. John M. Kirkwood, M.D. Usher Professor of Medicine, Dermatology, and translational Science, Univeristy of Pittsburgh School of Medicine and Director, Melanoma and Skin Cancer Program, Univeristy of Pittsburgh Cancer Institute Hillman Cancer Center.